Department of Nephrology, Shanxi Provincial People's Hospital (Fifth Hospital) of Shanxi Medical University, Taiyuan, Shanxi, China.
Second Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, China.
Clin Transplant. 2023 Nov;37(11):e15119. doi: 10.1111/ctr.15119. Epub 2023 Sep 19.
Focal segmental glomerulosclerosis is the most prevalent acquired kidney disease leading to end-stage renal disease in children and has a propensity for recurring in the transplanted kidney. The recurrence of FSGS after kidney transplantation in children varies greatly. In addition, the risk factors and outcomes of recurrence of FSGS remain controversial. This study evaluated the recurrence rate, risk factors, and prognosis of FSGS after kidney transplantation in order to provide advice and assistance in clinical decision-making for pediatric kidney transplantation.
PubMed, Embase, Web of Science, CNKI, and other databases were searched from the establishment of the repository to March 2022. We extracted data on incidence, risk factors, and outcomes.
The results showed that the recurrence rate of primary FSGS in children after renal transplantation was 48% (95% CI 36%-59%) and the recurrence rate of FSGS (all forms) was 35% (95% CI 17%-52%). The graft loss rate of primary FSGS in children after kidney transplantation was 29% (95% CI 17%-42%) and the graft loss rate of FSGS (all forms) was 29% (95% CI 4%-62%). 57% (95% CI 42%-73%) of pediatric patients with recurrent primary FSGS showed complete remission. Risk factor analyses showed that age of onset (SMD .69, 95% CI .20-1.19, p = .006) was related to the recurrence of primary FSGS, whereas the living related donor was not a risk factor for recurrent primary FSGS in pediatrics after kidney transplantation (OR 1.22, 95% CI .48-3.10, p = .674).
The recurrence rate and graft loss rate of FSGS in children after kidney transplantation were relatively high. Age at onset was associated with a risk for recurrent primary FSGS, whereas the living related donor was not a risk factor for recurrent FSGS in pediatric kidney recipients.
局灶节段性肾小球硬化症是导致儿童终末期肾病的最常见获得性肾脏疾病,并且在移植肾脏中易于复发。儿童肾移植后 FSGS 的复发率差异很大。此外,FSGS 复发的危险因素和结局仍存在争议。本研究评估了 FSGS 肾移植后复发率、危险因素和预后,以期为儿科肾移植的临床决策提供建议和帮助。
从数据库建立到 2022 年 3 月,检索了 PubMed、Embase、Web of Science、CNKI 等数据库。我们提取了发病、危险因素和结局的数据。
结果显示,儿童肾移植后原发性 FSGS 的复发率为 48%(95%CI 36%-59%),FSGS(所有形式)的复发率为 35%(95%CI 17%-52%)。儿童肾移植后原发性 FSGS 的移植物丢失率为 29%(95%CI 17%-42%),FSGS(所有形式)的移植物丢失率为 29%(95%CI 4%-62%)。57%(95%CI 42%-73%)的复发性原发性 FSGS 患儿完全缓解。危险因素分析显示,发病年龄(SMD.69,95%CI.20-1.19,p=.006)与原发性 FSGS 的复发有关,而活体亲属供者不是儿童肾移植后原发性 FSGS 复发的危险因素(OR 1.22,95%CI.48-3.10,p=.674)。
儿童肾移植后 FSGS 的复发率和移植物丢失率相对较高。发病年龄与原发性 FSGS 的复发风险相关,而活体亲属供者不是儿童肾移植后 FSGS 复发的危险因素。